Procyrion
Jeff Bird has been a life science investor for nearly twenty years at Sutter Hill Ventures. In 2019, he formed Bluebird Ventures. Jeff received an MD and PhD (Cancer Biology) degree from Stanford Medical School, and was a Stanford undergraduate.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Procyrion
Procyrion develops technology solutions and offers a catheter-based circulatory support technologies.